Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts

Transplant International

Volumn 27, Issue 11, 2014, Pages e118-e123

  Kanitakis, Jean ^a   Karayannopoulou, Georgia ^b   Lanzetta, Marco ^c   Petruzzo, Palmina ^a,d  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Italian Institute for Hand Surgery and Microsurgery   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

chronic rejection; graft vasculopathy; human hand allograft; vascularized composite allograft

Indexed keywords

BASILIXIMAB; CREATININE; MYCOPHENOLATE MOFETIL; PREDNISONE; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPOSITE GRAFT; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; DISEASE SEVERITY; DYSKERATOSIS; ENDOTHELIUM CELL; HAND; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; MAINTENANCE THERAPY; MALE; NECROSIS; PAPILLARY DERMIS; PAPULE; PLASMA CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIAL ARTERY; RADIAL NERVE; SKIN CAPILLARY; SKIN DISEASE; TREATMENT REFUSAL; VASCULAR DISEASE;

EID: 85027932803     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12399     Document Type: Article

References (21)

1. Dubernard JM, Owen E, Lefrançois N, et al. First human hand transplantation. Case report. Transpl Int 2000; 13(Suppl. 1): S521.
2. https://www.handregistry.com (accessed March 25, 2014).
3. Kanitakis J, Jullien D, Petruzzo P, et al. Clinicopathologic features of graft rejection in the first human hand allograft. Transplantation 2003; 76: 688.
4. Cendales L, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008; 8: 1396.
5. Petruzzo P, Gazarian A, Kanitakis J, et al. Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. Ann Surg 2014 (published online 18 March, doi: 10.1097/SLA.0000000000000627).
6. Diefenbeck M, Nerlich A, Schneeberger S, et al. Allograft vasculopathy after allogeneic vascularized knee transplantation. Transpl Int 2011; 24: e1.
7. Kaufman CL, Ouseph R, Blair B, et al. Graft vasculopathy in clinical hand transplantation. Am J Transplant 2012; 12: 1004.
8. Kanitakis J, McGregor B, Badet L, et al. Absence of C4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation 2007; 84: 265.
9. Pei G, Xiang D, Gu L, et al. A report of 15 hand allotransplantations in 12 patients and their outcomes in China. Transplantation 2012; 94: 1052.
10. Unadkat J, Schneeberger S, Horibe E, et al. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant 2010; 10: 251.
11. Mundinger GS, Munivenkatappa R, Drachenberg CB, et al. Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation. Transplantation 2013; 95: 1204.
12. Hautz T, Zelger B, Weissenbacher A, et al. Standardizing skin biopsy sampling to assess rejection in vascularized composite allotransplantation. Clin Transplant 2013; 27: E81–90.
13. Wood K, Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012; 93: 1.
14. Unadkat JV, Schneeberger S, Goldbach C, et al. Investigation of antibody-mediated rejection in composite tissue allotransplantation in a rat limb transplant model. Transplant Proc 2009; 41: 542.
15. Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation 2012; 93: 855.
16. Weissenbacher A, Hautz T, Zelger B, et al. Antibody-mediated rejection in hand transplantation. Transpl Int 2014; 27: e13.
17. Sarhane KA, Khalifian S, Ibrahim Z, et al. Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges. Clin Transplant 2014; 28: 277.
18. +-mediated rejection and C4d deposition in composite tissue (bilateral hand) recipients after induction with alemtuzumab. Transplantation 2009; 87: 776.
19. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14: 272.
20. Thaunat O. Pathophysiologic significance of B-cell clusters in chronically rejected grafts. Transplantation 2011; 92: 121.
21. Meuli-Simmen C, Eiman T, Alpert B, et al. Fibromuscular proliferation in finger arteries after hand replantation: a case report. Microsurgery 1996; 17: 551.